ArQule, Inc. (NASDAQ: ARQL) today announced that it will report its financial results for the third quarter of 2013 on Thursday, November 7, 2013 at 7:00 a.m. Eastern Time. The Company will hold a conference call at 9:00 a.m. Eastern Time that day to discuss these results.
Conference Call and Webcast
|Date:||Thursday, November 7, 2013|
|Time:||9:00 a.m., Eastern Time|
Conference Call Numbers
|Domestic (toll free):||(877) 868-1831|
A replay of the conference call will be available beginning two hours after the completion of the call through November 9, 2013 and can be accessed by dialing toll-free 855-859-2056 or 800-585-8367 and from outside the U.S. 404-537-3406. The confirmation code for replayed calls is 86068331.
ArQule is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company’s targeted, broad-spectrum products and research programs are focused on key biological processes that are central to human cancers. ArQule’s lead product, in Phase 2 and Phase 3 clinical development, is tivantinib (ARQ 197), an oral, selective inhibitor of the c-MET receptor tyrosine kinase. The Company’s pipeline includes: ARQ 092, designed to inhibit the AKT serine/threonine kinase, and ARQ 087, designed to inhibit fibroblast growth factor receptor (FGFR). ArQule’s current discovery efforts, which are based on the ArQule Kinase Inhibitor Platform (AKIP™), are focused on the identification of novel kinase inhibitors that are potent, selective and do not compete with ATP (adenosine triphosphate) for binding to the kinase.
|Gartner to Report Third Quarter 2013 Financial Results on November 7, 2013 (2013/10/23)|
|Insulet Corporation to Report Third Quarter 2013 Financial Results on November 7, 2013 ()|
|SouFun Holdings Limited to Report Third Quarter 2013 Financial Results on November 7, 2013 (2013/10/28)|
|Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013 (2013/10/30)|
|Bio-Rad to Report Third-Quarter 2013 Financial Results Thursday, November 7, 2013 ()|
|Demand Media to Announce Third Quarter 2013 Financial Results on November 7, 2013 ()|
|Ameresco to Announce Third Quarter 2013 Financial Results on November 7, 2013 (2013/10/24)|
|Hawaiian Electric Industries, Inc. To Announce Third Quarter 2013 Financial Results On November 7, 2013; American Savings Bank To Announce Third Quarter 2013 Financial Results On October 30, 2013 (2013/10/8)|
|Universal Electronics Inc. to Announce Third Quarter 2013 Financial Results on November 7, 2013 (2013/10/24)|
|Agios Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on November 7, 2013 (2013/10/31)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.